Price to Operating Profit (P/OP)
since 2005
Calculation
Boston Scientific Corp., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Operating income (loss)1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2023 | 41.05 | = | 47.18 | ÷ | 1.15 | 1.15 | = | 1,649 | ÷ | 1,434,780,104 | |
| Feb 23, 2022 | 52.01 | = | 43.71 | ÷ | 0.84 | 0.84 | = | 1,199 | ÷ | 1,426,724,712 | |
| Feb 23, 2021 | — | = | 38.75 | ÷ | -0.06 | -0.06 | = | -80 | ÷ | 1,417,165,707 | |
| Feb 25, 2020 | 36.71 | = | 39.91 | ÷ | 1.09 | 1.09 | = | 1,518 | ÷ | 1,396,195,349 | |
| Feb 19, 2019 | 36.68 | = | 39.86 | ÷ | 1.09 | 1.09 | = | 1,506 | ÷ | 1,385,961,926 | |
| Feb 20, 2018 | 28.71 | = | 26.83 | ÷ | 0.93 | 0.93 | = | 1,285 | ÷ | 1,374,910,797 | |
| Feb 23, 2017 | 74.67 | = | 24.48 | ÷ | 0.33 | 0.33 | = | 447 | ÷ | 1,363,488,640 | |
| Feb 24, 2016 | — | = | 17.33 | ÷ | -0.24 | -0.24 | = | -327 | ÷ | 1,348,346,253 | |
| Feb 25, 2015 | — | = | 16.92 | ÷ | -0.23 | -0.23 | = | -301 | ÷ | 1,330,512,367 | |
| Feb 26, 2014 | 147.21 | = | 13.34 | ÷ | 0.09 | 0.09 | = | 120 | ÷ | 1,324,192,809 | |
| Feb 22, 2013 | — | = | 7.37 | ÷ | -2.85 | -2.85 | = | -3,868 | ÷ | 1,357,426,289 | |
| Feb 17, 2012 | 9.78 | = | 6.09 | ÷ | 0.62 | 0.62 | = | 904 | ÷ | 1,451,346,240 | |
| Feb 17, 2011 | — | = | 7.40 | ÷ | -0.43 | -0.43 | = | -656 | ÷ | 1,523,368,979 | |
| Feb 26, 2010 | — | = | 7.74 | ÷ | -0.59 | -0.59 | = | -894 | ÷ | 1,511,368,790 | |
| Feb 27, 2009 | — | = | 7.02 | ÷ | -1.00 | -1.00 | = | -1,505 | ÷ | 1,502,237,400 | |
| Feb 28, 2008 | — | = | 12.72 | ÷ | -0.01 | -0.01 | = | -14 | ÷ | 1,492,320,521 | |
| Mar 1, 2007 | — | = | 16.21 | ÷ | -1.99 | -1.99 | = | -2,949 | ÷ | 1,480,340,219 | |
| Mar 1, 2006 | 20.37 | = | 24.00 | ÷ | 1.18 | 1.18 | = | 968 | ÷ | 821,567,300 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Boston Scientific Corp. Annual Report.
- Share Price Trend
- The share price exhibited a general decline from 24 US$ in March 2006 to a low point of 6.09 US$ in February 2012. After this period, there was a noticeable recovery and consistent upward trend, reaching a peak of 47.18 US$ by February 2023. This trajectory indicates an initial phase of reduced market valuation followed by a steady regain in investor confidence and market performance.
- Operating Profit Per Share (OPPS) Trend
- Operating profit per share demonstrated significant volatility throughout the period analyzed. Starting at 1.18 US$ in 2006, it dropped sharply into negative values in subsequent years, hitting lows such as -2.85 US$ in 2013. Post-2013, OPPS showed improvement and moved into positive territory with some fluctuations, peaking at 1.15 US$ in 2023. The oscillating OPPS underscores periods of operating challenges and recovery phases within the company’s financial performance.
- Price to Operating Profit Ratio (P/OP)
- The P/OP ratio data is sporadic and not consistently available for all years, but notable points include a high value of 147.21 in 2014 and a general range decrease afterward. The ratio fluctuates significantly, reflecting volatility in operating profit relative to share price. Lower ratios observed in more recent years compared to earlier high points suggest relatively improved operating profitability or adjustments in share price valuation mechanisms aligning more closely with operational earnings.
- Overall Financial Insights
- The combined data reveals a company undergoing considerable operational challenges reflected by negative operating profits in multiple years up to around 2013. However, the sustained recovery in share price and stabilization of operating profits in positive territory post-2013 indicates a successful turnaround. The improvement in OPPS alongside rising share price supports enhanced operational effectiveness and growing market confidence. The P/OP's variability reflects changing investor sentiment linked to operating profit volatility but generally points to better alignment between earnings and market valuation in recent years.
Comparison to Competitors
Boston Scientific Corp., P/OP, long-term trends, comparison to competitors
| Boston Scientific Corp. | Abbott Laboratories | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Feb 23, 2023 | 41.05 | 22.18 | 14.75 | 54.49 | 20.48 | 15.89 |
| Feb 23, 2022 | 52.01 | 24.45 | 10.43 | 56.11 | 37.44 | 18.77 |
| Feb 23, 2021 | — | 40.69 | 6.65 | 88.37 | 26.29 | 14.12 |
| Feb 25, 2020 | 36.71 | 34.03 | 7.83 | 48.89 | 21.26 | 14.40 |
| Feb 19, 2019 | 36.68 | 36.64 | 18.65 | 49.87 | 17.64 | 14.58 |
| Feb 20, 2018 | 28.71 | 60.88 | 7.44 | 44.40 | 22.64 | 14.42 |
| Feb 23, 2017 | 74.67 | 24.25 | 7.65 | 28.93 | 22.18 | 11.79 |
| Feb 24, 2016 | — | 19.80 | 10.49 | 27.25 | 28.81 | 9.59 |
| Feb 25, 2015 | — | 27.50 | 13.00 | 34.42 | 16.68 | 10.12 |
| Feb 26, 2014 | 147.21 | 22.79 | 10.12 | 17.96 | 11.80 | 7.22 |
| Feb 22, 2013 | — | 6.82 | 8.71 | 26.21 | — | 6.32 |
| Feb 17, 2012 | 9.78 | 15.35 | 9.11 | 27.83 | — | 6.55 |
| Feb 17, 2011 | — | 11.92 | 7.34 | 23.28 | — | 5.90 |
| Feb 26, 2010 | — | 13.54 | 7.29 | 33.47 | — | 5.95 |
| Feb 27, 2009 | — | 14.66 | 6.20 | 14.45 | — | 6.59 |
| Feb 28, 2008 | — | 18.76 | 12.09 | 55.84 | — | 7.62 |
| Mar 1, 2007 | — | 40.49 | 10.68 | 38.98 | — | 10.47 |
| Mar 1, 2006 | 20.37 | 15.48 | 12.37 | 50.21 | — | 14.87 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).